Activation of the Tubulo-Glomerular Feedback by SGLT2 Inhibitors in Patients With Type 2 Diabetes and Advanced Chronic Kidney Disease : Toward the End of a Myth?
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:45 |
|---|---|
| Enthalten in: |
Diabetes care - 45(2022), 10 vom: 01. Okt., Seite e148-e149 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Gérard, Alexandre O [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 28.09.2022 Date Revised 04.02.2023 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.2337/dc22-0921 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM344917444 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM344917444 | ||
| 003 | DE-627 | ||
| 005 | 20231226023855.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2337/dc22-0921 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1149.xml |
| 035 | |a (DE-627)NLM344917444 | ||
| 035 | |a (NLM)35973076 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Gérard, Alexandre O |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Activation of the Tubulo-Glomerular Feedback by SGLT2 Inhibitors in Patients With Type 2 Diabetes and Advanced Chronic Kidney Disease |b Toward the End of a Myth? |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 28.09.2022 | ||
| 500 | |a Date Revised 04.02.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 7 | |a Sodium-Glucose Transporter 2 Inhibitors |2 NLM | |
| 700 | 1 | |a Laurain, Audrey |e verfasserin |4 aut | |
| 700 | 1 | |a Favre, Guillaume |e verfasserin |4 aut | |
| 700 | 1 | |a Drici, Milou-Daniel |e verfasserin |4 aut | |
| 700 | 1 | |a Esnault, Vincent L M |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Diabetes care |d 1979 |g 45(2022), 10 vom: 01. Okt., Seite e148-e149 |w (DE-627)NLM00042983X |x 1935-5548 |7 nnns |
| 773 | 1 | 8 | |g volume:45 |g year:2022 |g number:10 |g day:01 |g month:10 |g pages:e148-e149 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2337/dc22-0921 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 45 |j 2022 |e 10 |b 01 |c 10 |h e148-e149 | ||